Joint conditions such as osteoarthritis can gradually damage cartilage, causing pain, stiffness and reduced movement. Because cartilage has a limited ability to repair itself, researchers are investigating new approaches that may help protect cartilage and influence the environment within the damaged joints.

One of the emerging areas of research focuses on mesenchymal stem cell-derived extracellular vesicles (MSC-EVs). These are the tiny membrane-bound particles naturally released by mesenchymal stem cells. They carry biological molecules such as proteins, lipids and genetic material (DNA or RNA) that can deliver signals to surrounding cells.

A 2026 review examined the potential role of MSC-EVs in osteoarthritis, rheumatoid arthritis and intervertebral disc degeneration. Laboratory and animal studies suggest that these vesicles may influence cartilage-cell survival, inflammation and extracellular matrix production, which is important for maintaining cartilage structure.

In osteoarthritis research, MSC-EVs have also been studied for their potential to support chondrocytes, the cells responsible for maintaining cartilage, while reducing inflammatory signalling and enzymes involved in cartilage breakdown.

Researchers are also interested in their immunomodulatory effects, as persistent inflammation can contribute to ongoing joint damage.

This research reflects a wider shift in regenerative medicine toward studying not only stem cells themselves, but also the biological signals they release.

Source:
Liu, T.M. (2026). MSC-EVs in Cartilage Regeneration and Immunomodulation: Mechanisms and Therapeutic Prospects for Osteoarthritis, Rheumatoid Arthritis and Intervertebral Disc Degeneration. International Journal of Molecular Sciences, [online] 27(18), p.8208. doi:10.3390/ijms27188208.

0
0
Your Cart
Your cart is emptyReturn to Shop